Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-20-019040

President & CEO bought 4,000 shares at $3.91 ($15,647)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
USMAN NASSIM President & CEO 2020-03-13 Purchase +4,000 $3.91 $15,647 11,010 D: show line 1 in the form
Open-market purchases · 4,000 sh · avg $3.91 · $15,647
Loading xslF345X03/doc4.xml…